Matthew Foy is Director & 10% Owner at Decibel Therapeutics, Inc. (DBTX). They have made 1 open-market trade across 1 company since 2021, most recently 2021-02-17.
CIK 0001842129
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.7M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DBTX | 458,487 | $2.3M |
Shares reported on the most recent Form 4, priced at the 2021-02-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DBTX | BUY | 2021-02-17 | 2021-02-19 | $18.00 | $2.7M | -9.8% | -30.2% | -56.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.